25 results on '"*CHEMICAL libraries"'
Search Results
2. Which boronic acids are used most frequently for synthesis of bioactive molecules?
- Author
-
Ertl, Peter, Altmann, Eva, Racine, Sophie, and Decoret, Odile
- Subjects
- *
BORONIC acids , *CHEMICAL libraries , *LIBRARY design & construction , *STRUCTURE-activity relationships , *MOLECULES , *CHEMISTS - Abstract
[Display omitted] Boronic acids are essential building blocks used for the synthesis of bioactive molecules, the generation of chemical libraries and the exploration of structure–activity relationships. As a result, more than ten thousand boronic acids are commercially available. Medicinal chemists are therefore facing a challenge; which of them should they select to maximize information obtained by the synthesis of new target molecules. The present article aims to help them to make the right choices. The boronic acids used frequently in the synthesis of bioactive molecules were identified by mining several large molecular and reaction databases and their properties were analyzed. Based on the results a diverse set of boronic acids covering well the bioactive chemical space was selected and is suggested as a basis for library design for the efficient exploration of structure–activity relationships. A Boronic Acid Navigator web tool which helps chemists to make their own selection is also made available at https://bit.ly/boronics. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Design and synthesis of boron-containing ALK inhibitor with favorable in vivo efficacy.
- Author
-
Ren, Jing, Gao, Yong, Shi, Wei, Xu, Sheng, Wang, Qinglin, Zhao, Damin, Kong, Lingming, Song, Wei, Wang, Xiaojin, Zhang, Ying, He, Xiangyi, Wang, Yan, Tong, Shunyu, Lu, Peng, Li, Yang, Xu, Hongjiang, and Zhang, Yinsheng
- Subjects
- *
MICROSOMES , *NON-small-cell lung carcinoma , *CHEMICAL libraries , *PHARMACEUTICAL chemistry , *LIVER microsomes , *DRUG design - Abstract
[Display omitted] • A boron-containing compound library was constructed and screened. • Lead compound 10 k has favorable in vitro metabolic stability and in vivo efficacy. • Molecular simulation analysis shows that the binding model is novel and differentiated. • It is the first publicly reported lead compound for boron-containing ALK inhibitor. ALK is an attractive therapeutic target for the treatment of non-small cell lung cancer. As an emerging element in medicinal chemistry, boron has achieved great success in the discovery of antitumor drugs and antibacterial agents. Through construction of a BCC (boron-containing compound) compound library and broad kinase screening, we found the ALK inhibitor hit compound 10a. Structural optimization by CADD and isosterism revealed that lead compound 10k has improved activity (ALKL1196M IC 50 = 8.4 nM, NCI-H2228 cells IC 50 = 520 nM) and better in vitro metabolic stability (human liver microsomes, T 1/2 = 238 min). Compound 10k showed good in vivo efficacy in a nude mouse NCI-H2228 lung cancer xenograft model with a TGI of 52 %. Molecular simulation analysis results show that the hydroxyl group on the oxaborole forms a key hydrogen bond with Asn1254 or Asp1270, and this binding site provides a new idea for drug design. This is the first publicly reported lead compound for a boron-containing ALK inhibitor. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
- Author
-
Le, Nguyen-Hung, Constant, Patricia, Tranier, Samuel, Nahoum, Virginie, Guillet, Valérie, Maveyraud, Laurent, Daffé, Mamadou, Mourey, Lionel, Verhaeghe, Pierre, and Marrakchi, Hedia
- Subjects
- *
SALICYLANILIDES , *DRUG discovery , *TUBERCULOSIS , *MYCOBACTERIUM tuberculosis , *PYRAZINAMIDE , *CHEMICAL libraries - Abstract
[Display omitted] Tuberculosis (TB) remains a global health crisis, further exacerbated by the slow pace of new treatment options, and the emergence of extreme and total drug resistance to existing drugs. The challenge to developing new antibacterial compounds with activity against Mycobacterium tuberculosis (Mtb), the causative agent of TB, is in part due to unique features of this pathogen, especially the composition and structure of its complex cell envelope. Therefore, targeting enzymes involved in cell envelope synthesis has been of major interest for anti-TB drug discovery. FAAL32 is a fatty acyl-AMP ligase involved in the biosynthesis of the cell wall mycolic acids, and a potential target for drug discovery. To rapidly advance research in this area, we initiated a drug repurposing campaign and screened a collection of 1280 approved human or veterinary drugs (Prestwick Chemical Library) using a biochemical assay that reads out FAAL32 inhibition. These efforts led to the discovery of salicylanilide closantel, and some of its derivatives as inhibitors with potent in vitro activity against M. tuberculosis. These results suggest that salicylanilide represents a potentially promising pharmacophore for the conception of novel anti-tubercular candidates targeting FAAL32 that would open new targeting opportunities. Moreover, this work illustrates the value of drug repurposing campaigns to discover new leads in challenging drug discovery fields. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Synthesis and evaluation of 1,2,3-dithiazole inhibitors of the nucleocapsid protein of feline immunodeficiency virus (FIV) as a model for HIV infection.
- Author
-
Laitinen, Tuomo, Meili, Theres, Koyioni, Maria, Koutentis, Panayiotis A., Poso, Antti, Hofmann-Lehmann, Regina, and Asquith, Christopher R.M.
- Subjects
- *
FELINE immunodeficiency virus , *STRUCTURE-activity relationships , *HIV , *CHEMICAL libraries - Abstract
[Display omitted] We disclose a series of potent anti-viral 1,2,3-dithiazoles, accessed through a succinct synthetic approach from 4,5-dichloro-1,2,3-dithiazolium chloride (Appel's salt). A series of small libraries of compounds were screened against feline immunodeficiency virus (FIV) infected cells as a model for HIV. This approach highlighted new structure activity relationship understanding and led to the development of sub-micro molar anti-viral compounds with reduced toxicity. In addition, insight into the mechanistic progress of this system is provided via advanced QM-MM modelling. The 1,2,3-dithiazole represents a versatile scaffold with potential for further development to treat both FIV and HIV. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Design, synthesis, and structure–activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.
- Author
-
Yasuda, Yorinobu, Arakawa, Takeaki, Nawata, Yumi, Shimada, Sayaka, Oishi, Shinya, Fujii, Nobutaka, Nishimura, Shinichi, Hattori, Akira, and Kakeya, Hideaki
- Subjects
- *
DRUG design , *CARBOXAMIDES , *CHEMICAL synthesis , *HYPOXIA-inducible factor 1 , *ENZYME inhibitors , *CANCER chemotherapy , *CHEMICAL libraries - Abstract
Hypoxia-inducible factor (HIF)-1 is well known as a promising target for cancer chemotherapy. By screening an in-house chemical library using a hypoxia-responsive luciferase reporter gene assay, we identified CLB-016 ( 1 ) containing 1-ethylpyrazole-3-carboxamide as a HIF-1 inhibitor (IC 50 = 19.1 μM). In a subsequent extensive structure-activity relationship (SAR) study, we developed compound 11Ae with an IC 50 value of 8.1 μM against HIF-1-driven luciferase activity. Compounds 1 and 11Ae were shown to significantly suppress the HIF-1-mediated hypoxia response, including carbonic anhydrase IX (CAIX) gene expression and migration of human sarcoma HT1080 cells. These results revealed 1-ethylpyrazole-3-carboxamide as a novel scaffold to develop promising anti-cancer drugs targeting the HIF-1 signaling pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Virtual screening and further development of novel ALK inhibitors
- Author
-
Okamoto, Masako, Kojima, Hirotatsu, Saito, Nae, Okabe, Takayoshi, Masuda, Yoshiaki, Furuya, Toshio, and Nagano, Tetsuo
- Subjects
- *
DRUG development , *LUNG cancer treatment , *ENZYME inhibitors , *CELL receptors , *AMINOPYRIDINES , *ANTINEOPLASTIC agents , *CHEMICAL libraries - Abstract
Abstract: Anaplastic lymphoma kinase (ALK) has been in the spotlight in recent years as a promising new target for therapy of non-small-cell lung cancer (NSCLC). Since the identification of the echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusion gene in some NSCLC patients was reported in 2007, various research groups have been seeking ALK inhibitors. Above all, crizotinib (PF-02341066) has been under clinical trial, and its therapeutic efficacy of inhibiting ALK in NSCLC has been reported. Among anticancer drugs, drug resistance appears frequently necessitating various kinds of inhibitors. We identified novel ALK inhibitors by virtual screening from the public chemical library collected by the Chemical Biology Research Initiative (CBRI) at the University of Tokyo, and inhibitors that are more potent were developed. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
8. Identification of novel ASK1 inhibitors using virtual screening
- Author
-
Okamoto, Masako, Saito, Nae, Kojima, Hirotatsu, Okabe, Takayoshi, Takeda, Kohsuke, Ichijo, Hidenori, Furuya, Toshio, and Nagano, Tetsuo
- Subjects
- *
MITOGEN-activated protein kinases , *APOPTOSIS , *CHEMICAL libraries , *TARGETED drug delivery , *ANTINEOPLASTIC agents , *CARDIOVASCULAR diseases , *DRUG use testing , *ENZYME inhibitors , *INFLAMMATION - Abstract
Abstract: Apoptosis signal-regulating kinase 1 (ASK1, also called MAP3K5) is a mitogen-activated protein kinase kinase kinase (MAP3K) that plays important roles in stress-induced cell death and inflammation, and is expected as a new therapeutic target for cancer, cardiovascular diseases, and neurodegenerative diseases. We identified novel ASK1 inhibitors by virtual screening from the public chemical library collected by Chemical Biology Research Initiative (CBRI) at the University of Tokyo. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
9. A new small molecule that directly inhibits the DNA binding of NF-κB
- Author
-
Kobayashi, Takanobu, Yoshimori, Atsushi, Kino, Katsuhito, Komori, Rie, Miyazawa, Hiroshi, and Tanuma, Sei-ich
- Subjects
- *
NF-kappa B , *DNA-binding proteins , *TARGETED drug delivery , *DRUG development , *CHEMICAL libraries , *HYDROGEN bonding , *CLINICAL drug trials - Abstract
Abstract: Nuclear factor-κB (NF-κB) has been considered as a good target for the treatment of many diseases. Although a lot of NF-κB inhibitors have already been reported, many of them have several common problems. Thus, we attempted to identify novel NF-κB inhibitors to be unique lead compounds for creating new pharmaceuticals. In the present study, we screened our chemical library for compounds that directly inhibit the DNA binding of NF-κB by using fluorescence correlation spectroscopy (FCS). Consequently, we identified a promising compound, 4,6-dichloro-N-phenyl-1,3,5-triazin-2-amine, referred to as NI241. It mediated a dose-dependent inhibition of the DNA binding of NF-κB p50. Its analogues also showed dose-dependent inhibition and their inhibitory effects were altered by the substituents on the N-phenyl group. Furthermore, we predicted the binding mode of NI241 with p50 in silico. In this model, NI241 forms three hydrogen bonds with Tyr60, His144, and Asp242 on p50, which are important amino acid residues for the interaction with DNA. These results suggest that NI241 with structural novelty may serve as a useful scaffold for the creation of new NF-κB inhibitors by rational optimization. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
10. γ-Pyrone natural products—A privileged compound class provided by nature
- Author
-
Wilk, Wolfram, Waldmann, Herbert, and Kaiser, Markus
- Subjects
- *
BIOLOGICAL products , *CHEMICAL libraries , *BIOSYNTHESIS , *ORGANIC cyclic compounds , *CHEMICAL biology , *BIODIVERSITY - Abstract
Abstract: In “Biology Oriented Synthesis” (BIOS), the inherent biological relevance of natural products is employed for the design and synthesis of compound libraries. Towards this end, library generation in BIOS is focused on compound classes from biologically relevant space such as the natural product space or also the drug space and only scaffolds of these areas of proven relevance are employed for synthesis of small focused libraries with limited diversity. We here present a short overview of γ-pyrone natural products, highlighting their biological properties and their potential applicability in a BIOS of a compound library. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
11. Structure-based virtual screening for novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase and their experimental evaluation
- Author
-
Deye, Joel, Elam, Christopher, Lape, Michael, Ratliff, Robert, Evans, Kayla, and Paula, Stefan
- Subjects
- *
HIGH throughput screening (Drug development) , *ENZYME inhibitors , *EFFECT of drugs on calcium channels , *CHEMICAL libraries , *CANCER chemotherapy , *X-ray crystallography - Abstract
Abstract: A public compound library with 260,000 compounds was screened virtually by computational docking for novel inhibitors of the transmembrane enzyme sarco/endoplasmic reticulum calcium ATPase (SERCA). Docking was performed with the program GOLD in conjunction with a high resolution X-ray crystal structure of SERCA. Compounds that were predicted to be active were tested in bioassays. Nineteen novel compounds were discovered that were capable of inhibiting the ATP hydrolysis activity of SERCA at concentrations below 50μM. Crucial enzyme/inhibitor interactions were identified by analyzing the docking-predicted binding poses of active compounds. Like other SERCA inhibitors, the newly discovered compounds are of considerable medicinal interest because of their potential for cancer chemotherapy. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
12. Using specificity to strategically target proteases
- Author
-
Lim, Mark D. and Craik, Charles S.
- Subjects
- *
PROTEOLYTIC enzymes , *PHARMACEUTICAL chemistry , *IMMUNOSPECIFICITY , *BINDING sites , *MOLECULAR probes , *BIOLOGICAL assay , *CHEMICAL libraries - Abstract
Abstract: Proteases are a family of naturally occurring enzymes in the body whose dysregulation has been implicated in numerous diseases and cancers. Their ability to selectively and catalytically turnover substrate adds both signal amplification and functionality as parameters for the detection of disease. This review will focus on the development of activity-based methodologies to characterize proteases, and in particular, the use of positional scanning, synthetic combinatorial libraries (PS-SCL’s), and substrate activity screening (SAS) assays. The use of these approaches to better understand a protease’s natural substrate will be discussed as well as the technologies that emerged. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
13. A road less traveled by: Exploring a decade of Ellman chemistry
- Author
-
Shelat, Anang A. and Guy, R. Kiplin
- Subjects
- *
MEDICAL research , *CHEMICAL libraries , *NATURAL products , *MOLECULAR probes , *BIOMOLECULES - Abstract
Abstract: The Ellman group has been one of the most influential in the development and widespread adoption of combinatorial chemistry techniques for biomedical research. Their work has included substantial methodological development for library synthesis with a particular focus on new scaffolds rationally targeted to biomolecules of interest and biologically relevant natural products. Herein we analyze a representative set of libraries from this group with respect to their biological and biomedical relevance in comparison to existing drugs and probe compounds. This analysis reveals that the Ellman group has not only provided new methodologies to the community but also provided libraries with unique potential for further biological study. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
14. Synthesis and screening of a cyclic peptide library: Discovery of small-molecule ligands against human prolactin receptor
- Author
-
Liu, Tao, Joo, Sang Hoon, Voorhees, Jeffrey L., Brooks, Charles L., and Pei, Dehua
- Subjects
- *
PEPTIDE synthesis , *CYCLIC peptides , *HIGH throughput screening (Drug development) , *CHEMICAL libraries , *HORMONE receptors , *MASS spectrometry - Abstract
Abstract: Prolactin receptor is involved in normal lactation and reproduction; however, excessive prolactin levels can cause various reproductive disorders such as prolactinomas. Small-molecule antagonists against the human prolactin receptor (hPRLr) thus have potential clinical applications and may serve as useful molecular probes in biomedical research. In this work, we synthesized a large, support-bound cyclic peptide library (theoretical diversity of 1.2×107) on 90-μm TentaGel beads and screened it against the extracellular domain of hPRLr. To facilitate hit identification, each TentaGel bead was spatially segregated into outer and inner layers, with a cyclic peptide displayed on the bead surface while the bead interior contained the corresponding linear peptide. The identity of a positive bead was revealed by sequencing the linear encoding peptide within the bead by partial Edman degradation/mass spectrometry. Screening of the library resulted in 20 hits, two of which were selected for further analysis and shown to bind to hPRLr with dissociation constants of 2–3μM. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
15. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-κB
- Author
-
Kang, Soo Sung, Cuendet, Muriel, Endringer, Denise C., Croy, Vicki L., Pezzuto, John M., and Lipton, Mark A.
- Subjects
- *
RESVERATROL , *DRUG derivatives , *CYCLOOXYGENASES , *CYCLOOXYGENASE 2 inhibitors , *NF-kappa B , *CHEMICAL libraries - Abstract
Abstract: Resveratrol (4,3′,5′-trihydroxystilbene) is a naturally occurring antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and the transcription factor NF-κB. A 78-membered library of resveratrol analogues in which the substituents on the two aryl rings and alkene were varied was synthesized using a solid-phase Wittig olefination reaction. The library contains inhibitors against all three proteins that were more potent than resveratrol itself. Preliminary structure–activity relationships were also obtained from these data that permitted the derivation of pharmacophore models for each of the three targets. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
16. On-bead cyclization in a combinatorial library of 15,625 octapeptides
- Author
-
Fluxa, Viviana S. and Reymond, Jean-Louis
- Subjects
- *
CYCLIC peptides , *RING formation (Chemistry) , *CHEMICAL libraries , *SOLID-phase synthesis , *AMINO acid analysis , *CHEMICAL bonds - Abstract
Abstract: Combinatorial peptide libraries prepared by split-and-mix synthesis on solid support can be decoded by amino acid analysis (AAA) using the TAGSFREE method, which assigns variable amino acids to ‘unique pair’ positions. The method was used here to investigate on-bead cyclization in a library of 15,625 octapeptides X8X7X6X5X4-Lys-X2-glu(β-Ala-β-Ala-TentaGel Macrobead)-OAllyl, anchored via the side-chain carboxylate of the d-glutamate. Cyclization was carried out by amide bond formation between the free N-terminus and the α-carboxyl group of d-glutamate after selective removal of the Fmoc and allyl protecting groups, and followed using the TNBS test for free amines. Fast-cyclizing sequences often contained a turn element, in particular Ala-(Asp/Thr)-Pro at X8-X7-X6, and phenylalanine at X2. Slow-cyclizing sequences contained predominantly basic and polar residues, in particular Arg-His-Ser at X7-X6-X5 and threonine at X8. Fast-cyclizing sequences gave higher preparative yields of cyclic peptides (22–26% purified yields) than slow-cyclizing sequences (6–8%), showing that fast reaction is associated with efficient cyclization. This experiment demonstrates the first use of a TAGSFREE library of cyclic peptides. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
17. Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library
- Author
-
Tsou, En-Lun, Chen, Sih-Yu, Yang, Ming-Hsun, Wang, Shih-Chi, Cheng, Ting-Ren Rachel, and Cheng, Wei-Chieh
- Subjects
- *
PYRROLIDINE , *ORGANIC synthesis , *NATURAL products , *CHEMICAL libraries , *GLUCOSIDASE inhibitors , *RING formation (Chemistry) - Abstract
Abstract: Inspired by polyhydroxylated pyrrolidine alkaloid natural products, a 18-membered library of 2-aryl polyhydroxylated pyrrolidines has been efficiently prepared in two or three synthetic steps from the known chiral cyclic nitrones with high yield and purity and excellent stereoselectivity. The inhibitory activity of all these compounds against various glycosidase enzymes was evaluated. Interestingly, 15 and 19 show better inhibitory activities than radicamine A (20) and B (18) against α-glucosidases. The IC50 values of 15 and 19 are 1.1 and 0.5μM, respectively. In this study, we also discovered the substituent(s) on the aryl ring could affect the inhibition potency and selectivity against glycosidases. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
18. Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1
- Author
-
Meadows, D. Christopher, Sanchez, Tino, Neamati, Nouri, North, Thomas W., and Gervay-Hague, Jacquelyn
- Subjects
- *
CHEMICAL libraries , *HIV , *VIRUS inhibitors , *FIRE assay - Abstract
Abstract: In a previous study, we prepared a small library of chicoric acid analogs that possessed both potent anti-integrase and antiviral activity. It was also shown that active compounds fell into one of two groups: those that inhibited an early stage in viral replication and those that inhibited at a later stage. In this study, a series of vinyl geminal disulfone-containing compounds possessing a range of ring substituents has been synthesized to probe the impact of structure on inhibitory mechanisms. Four active compounds were identified using HIV drug susceptibility assays. Three of the inhibitors possessing either no substituents or electron-withdrawing substituents on the aromatic rings led to high levels of cytotoxicity and antiviral activity. Intrigued by the potential implications of electronic effects on activity, we probed whether the active compounds could be nonspecifically reacting via 1,4-addition. To investigate this hypothesis, the compounds were incubated with glutathione and upon LC/MS analysis, molecular ion peaks corresponding to both mono and double addition adducts were identified. Second, we synthesized analogs lacking the ability to participate in 1,4-addition and tested them for antiviral activity and cytotoxicity, and found the compounds inactive for both activities. Taken together, the studies reported herein suggest that compounds lacking electron-donating substituents on the aromatic ring are promiscuous acceptors of biological nucleophiles, whereas compounds possessing electron-donating substituents seem to resist addition or at least be more selective and significantly less toxic. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
19. Synthesis and high-throughput evaluation of triskelion uracil libraries for inhibition of human dUTPase and UNG2
- Author
-
Jiang, Yu Lin, Chung, Suhman, Krosky, Daniel J., and Stivers, James T.
- Subjects
- *
DNA , *DEOXYRIBOSE , *GENES , *ENZYMES - Abstract
Abstract: Human nuclear uracil DNA glycosylase (UNG2) and deoxyuridine triphosphate nucleotidohydrolase (dUTPase) are the primary enzymes that prevent the incorporation and accumulation of deoxyuridine in genomic DNA. These enzymes are desirable targets for small molecule inhibitors given their roles in a wide range of biological processes ranging from chromosomal rearrangements that lead to cancer, viral DNA replication, and the formation of toxic DNA strand breaks during anticancer drug therapy. To accelerate the discovery of such inhibitors, we have developed a high-throughput approach for directed library synthesis and screening. In this efficient technology, a uracil-aldehyde ligand is covalently tethered to one position of a trivalent alkyloxyamine linker via an oxime linkage, and then the vacant linker positions are derivatized with a library of aldehydes. The resulting triskelion oximes were directly screened for inhibitory activity and the most potent of these showed micromolar binding affinities to UNG2 and dUTPase. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
20. Design and construction of a stereochemically diverse piperazine-based DNA-encoded chemical library.
- Author
-
Chamakuri, Srinivas, Chung, Mee-Kyung, Samuel, Errol L.G., Tran, Kevin A., Chen, Ying-Chu, Nyshadham, Pranavanand, Santini, Conrad, Matzuk, Martin M., and Young, Damian W.
- Subjects
- *
CHEMICAL libraries , *ENANTIOMERIC purity , *PIPERAZINE , *PLACE attachment (Psychology) - Abstract
Here we report the successful construction of a novel, stereochemically diverse DNA-Encoded Chemical Library (DECL) by utilizing 24 enantiomerically pure trifunctional 2, 6- di-substituted piperazines as central cores. We introduce the concept of positional diversity by placing the DNA attachment at either of two possible sites on the piperazine scaffold. Using a wide range of building blocks, a diverse library of 77 million compounds was produced. Cheminformatic analysis demonstrates that this library occupies a wide swath of chemical space, and that the piperazine scaffolds confers different shape diversity compared to the commonly used triazine core. [Display omitted] Here we report the successful construction of a novel, stereochemically diverse DNA-Encoded Chemical Library (DECL) by utilizing 24 enantiomerically pure trifunctional 2, 6- di-substituted piperazines as central cores. We introduce the concept of positional diversity by placing the DNA attachment at either of two possible sites on the piperazine scaffold. Using a wide range of building blocks, a diverse library of 77 million compounds was produced. Cheminformatic analysis demonstrates that this library occupies a wide swath of chemical space, and that the piperazine scaffolds confers different shape diversity compared to the commonly used triazine core. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library.
- Author
-
Zhou, Yu, Shen, Wenyin, Peng, Jianzhao, Deng, Yuqing, and Li, Xiaoyu
- Subjects
- *
HIGH throughput screening (Drug development) , *CHEMICAL libraries , *MOLECULAR weights , *PROTEIN domains - Abstract
[Display omitted] DNA-encoded chemical library (DEL) has emerged to be a powerful ligand screening technology in drug discovery. Recently, we reported a DNA-encoded dynamic library (DEDL) approach that combines the principle of traditional dynamic combinatorial library (DCL) with DEL. DEDL has shown excellent potential in fragment-based ligand discovery with a variety of protein targets. Here, we further tested the utility of DEDL in identifying low molecular weight fragments that are selective for different isoforms or domains of the same protein family. A 10,000-member DEDL was selected against sirtuin-1, 2, and 5 (SIRT1, 2, 5) and the BD1 and BD2 domains of bromodomain 4 (BRD4), respectively. Albeit with modest potency, a series of isoform/domain-selective fragments were identified and the corresponding inhibitors were derived by fragment linking. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. On the design of lead-like DNA-encoded chemical libraries.
- Author
-
Castan, Isaline F.S.F., Graham, Jessica S., Salvini, Catherine L.A., Stanway-Gordon, Harriet A., and Waring, Michael J.
- Subjects
- *
CHEMICAL libraries , *MOLECULAR weights , *MONOMERS , *LEAD compounds - Abstract
[Display omitted] DNA-encoded libraries (DELs) are becoming an established technology for finding ligands for protein targets. We have abstracted and analysed libraries from the literature to assess the synthesis strategy, selections of reactions and monomers and their propensity to reveal hits. DELs have led to hit compounds across a range of diverse protein classes. The range of reactions and monomers utilised has been relatively limited and the hits are often higher in molecular weight than might be considered ideal. Considerations for future library designs with reference to chemical diversity and lead-like properties are discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry.
- Author
-
Guilinger, John P., Archna, Archna, Augustin, Martin, Bergmann, Andreas, Centrella, Paolo A., Clark, Matthew A., Cuozzo, John W., Däther, Maike, Guié, Marie-Aude, Habeshian, Sevan, Kiefersauer, Reiner, Krapp, Stephan, Lammens, Alfred, Lercher, Lukas, Liu, Julie, Liu, Yanbin, Maskos, Klaus, Mrosek, Michael, Pflügler, Klaus, and Siegert, Markus
- Subjects
- *
X-ray crystallography technique , *BRUTON tyrosine kinase , *CHEMICAL libraries , *SMALL molecules , *COMBINATORIAL chemistry , *ACRYLAMIDE - Abstract
[Display omitted] Libraries of DNA-Encoded small molecules created using combinatorial chemistry and synthetic oligonucleotides are being applied to drug discovery projects across the pharmaceutical industry. The majority of reported projects describe the discovery of reversible, i.e. non-covalent, target modulators. We synthesized multiple DNA-encoded chemical libraries terminated in electrophiles and then used them to discover covalent irreversible inhibitors and report the successful discovery of acrylamide- and epoxide-terminated Bruton's Tyrosine Kinase (BTK) inhibitors. We also demonstrate their selectivity, potency and covalent cysteine engagement using a range of techniques including X-ray crystallography, thermal transition shift assay, reporter displacement assay and intact protein complex mass spectrometry. The epoxide BTK inhibitors described here are the first ever reported to utilize this electrophile for this target. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. Diversity-oriented synthesis as a tool to expand the chemical space of DNA-encoded libraries.
- Author
-
Lenci, Elena, Baldini, Lorenzo, and Trabocchi, Andrea
- Subjects
- *
BIOLOGICAL laboratories , *SPACE exploration , *DOSAGE forms of drugs , *CHEMICAL plants , *CHEMICAL libraries - Abstract
[Display omitted] DNA-encoded libraries (DEL) represent a powerful technology for generating compound collections for drug discovery campaigns, that have allowed for the selection of many hit compounds over last three decades. However, the application of split-and-pool combinatorial methodologies, as well as the limitation imposed by DNA-compatible chemistry, has often brought to a limited exploration of the chemical space, with an over-representation of flat aromatic or peptide-like structures, whereas a higher scaffold complexity is generally associated with a more successful biological activity of the library. In this context, the application of Diversity-Oriented Synthesis, capable of creating sp3-rich molecular entities even starting from simple flat building blocks, can represent an efficient strategy to significantly broaden the chemical space explored by DELs. In this review, we present selected examples of DNA-compatible complexity-generating reactions that can be applied for the generation of DNA-encoded DOS libraries, including: (i) multicomponent reactions; (ii) C-H/C-X functionalization; (iii) tandem approaches; (iv) cycloadditions; (v) reactions introducing privileged elements. Also, selected case studies on the generation of DELs with high scaffold diversity are discussed, reporting their application in drug discovery programs. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
25. Large screening of DNA-compatible reaction conditions for Suzuki and Sonogashira cross-coupling reactions and for reverse amide bond formation.
- Author
-
Favalli, Nicholas, Bassi, Gabriele, Bianchi, Davide, Scheuermann, Jörg, and Neri, Dario
- Subjects
- *
SONOGASHIRA reaction , *SUZUKI reaction , *CARBOXYLIC acid derivatives , *CHEMICAL libraries , *DNA synthesis , *AROMATIC amines , *CHEMICAL synthesis - Abstract
[Display omitted] Progress in DNA-encoded chemical library synthesis and screening crucially relies on the availability of DNA-compatible reactions, which proceed with high yields and excellent purity for a large number of possible building blocks. In the past, experimental conditions have been presented for the execution of Suzuki and Sonogashira cross-coupling reactions on-DNA. In this article, our aim was to optimize Suzuki and Sonogashira reactions, comparing our results to previously published procedures. We have tested the performance of improved conditions using 606 building blocks (including boronic acids, pinacol boranes and terminal alkynes), achieving >70% conversion for 84% of the tested molecules. Moreover, we describe efficient experimental conditions for the on-DNA synthesis of amide bonds, starting from DNA derivatives carrying a carboxylic acid moiety and 300 primary, secondary and aromatic amines, as amide bonds are frequently found in DNA-encoded chemical libraries thanks to their excellent DNA compatibility. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.